Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023890 (
cirrhosis
)
42,195
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
One hundred twenty-five infants underwent surgical intervention for necrotizing enterocolitis between 1972 and 1984. Sixty-three infants, who survived more than 30 days postoperatively, were evaluated for long-term complications. There were 28 girls and 35 boys (mean birth weight 1,725 +/- 890 g; gestational age 32 +/- 4 weeks). Associated problems included hyaline membrane disease (43), cardiac anomalies (25), and trisomy 21(2). Thirty-six survivors required long-term ventilatory support. Fifty-nine infants underwent bowel resection and enterostomy, 3 decompressing enterostomies without resection, and 1, exploratory laparotomy only. Enterostomies were closed at four months. Twenty four had short bowel syndrome. Fifteen infants subsequently died for a late mortality rate of 23%. Mortality was related to sepsis (3), respiratory failure (5), cardiac anomalies (3), cardio-respiratory arrest (2), and
TPN
related liver failure (2), and was common with gestational age less than 31 weeks and birth weight less than 1,000 g. Medical problems included cholestasis (17),
TPN
induced
cirrhosis
(3), meningitis (3), seizures (8), and nutritional rickets (6). Significant developmental and intellectual delays were observed.
...
PMID:Long-term follow-up after surgical management of necrotizing enterocolitis: sixty-three cases. 372 6
Hepatobiliary dysfunctions (
TPN
-HBD) occur during parenteral nutrition. In older children these are usually reversible whereas in newborns and infants these hepatobiliary abnormalities play a significant role in the morbidity. Cholestasis is a commonly occurring
TPN
-HBD. It correlates directly with the decreasing gestational age, low birth weight and increasing duration of
TPN
therapy. The pathogenesis of cholestasis of
TPN
is multifactorial and predisposed by necrotising enterocolitis, sepsis, cardiac failure, shock, and hypotension. Diagnosis is made with exclusion of other causes of direct hyperbilirubinemia. Most
TPN
-HBD appear within 4 weeks of starting of
TPN
but severe complications manifest usually after the 16th week. Histologically there is intralobular cholestasis. In few cases there may be severe portal fibrosis followed by development of micronodular biliary
cirrhosis
. Enteral starvation, defective bile acid carriers, hypercaloric
TPN
are the major factors responsible for
TPN
-HBD, including cholestasis. Biliary complications of
TPN
-HBD are acalculous, cholecystitis, and cholelithiasis. Bile stasis is a major pathological factor for these. If the calories are provided only by glucose or glucose-containing electrolyte solutions it may lead to cholestasis and other
TPN
-HBD. Even small oral alimentation (continuous or bolus) during
TPN
, prevent
TPN
-HBD. Choleretic agents have been useful in the prevention and management of cholestasis and other parenteral nutrition induced hepatobiliary abnormalities.
...
PMID:Hepatobiliary abnormalities and parenteral nutrition. 1102 27
This study was designed to investigate the effects of different
TPN
on liver regeneration after partial hepatectomy in rats. Forty Wistar rats were randomly divided into four groups. Groups A and B (normal rats) received BCAA-enriched
TPN
(45% BCAAs) and standard
TPN
(24% BCAAs) respectively after 34% hepatectomy; Groups C and D (rats with
cirrhosis
of liver) received the same
TPN
as Groups A and B received respectively after 34% hepatectomy. On the third day after operation, all rats were killed and specimens of liver and blood were taken for measurement of activity of liver regeneration. The results showed that DNA synthesis rate and mitosis rate in Groups A and B were significantly greater than those in Groups C and D respectively; RLR, DNA synthesis rate and mitosis rate in Groups A and C were significantly higher than those in Groups B and D respectively. These suggest that the effect of the same
TPN
on liver regeneration in normal rats is better than that in
cirrhosis
rats and that BCAA-enriched
TPN
can provide more excellent supplementation than standard
TPN
can do either in normal liver or
cirrhosis
liver after partial hepatectomy.
...
PMID:[Influence of different total parenteral nutrition support upon hepatic regeneration after partial hepatectomy in rats]. 1221 89
During the last years, clinical small bowel transplantation has significantly improved. This is especially true for isolated small bowel transplantation with success rates of 80 % 1-year patient survival. Currently, approximately 100 small bowel transplantations are performed per year worldwide. In Germany, small bowel transplantation is still rare, because of the high risk for the development of acute rejection and rejection-associated complications. This includes peritonitis and sepsis as well as over-immunosuppression-associated infections. Due to improvements in immunosuppression, the incidence of acute rejection decreased from about 85 % below 25 %. Half of the patients will receive a combined liver-small bowel graft due to
TPN
(total parenteral nutrition)-associated
liver cirrhosis
. Although the combined procedure has immunological advantages, complication rates are high and patient survival is significantly lower (ca. 50 % at 1 year). Next to bacterial, fungal, and atypic infections, which are frequently associated with rejection and other complications, CMV and EBV infections are of significant interest. This is of special importance for EBV infections, since all PTLD (lymphoproliferative disease) after small bowel transplantation are EBV-associated so far. Viral infections should be monitored and preemptive therapy using ganciclovir or foscavir will be initiated. Of the 800 patients transplanted so far, 50 % are still alive up to 15 years. Of these, more than 80 % are off parenteral nutrition, in good healths, with good quality of live.
...
PMID:[Small bowel transplantation - current status and initial results]. 1462 34
Parenteral nutrition is a life-saving treatment for patients who have acute and chronic intestinal failure. Severe cholestasis induced by total parental nutrition (
TPN
-IC) is characterized by bile duct regeneration, portal inflammation, and fibrosis. Its progression could be very rapid, and in some patients
liver cirrhosis
may develop in few months. This article describes the definition, incidence, hepatic changes, histopathologic findings, risk factors, pathogenesis, and clinical implications of
TPN
-IC. The goal is to improve hospital and home management, quality of life, and prognosis of patients requiring parenteral nutrition.
...
PMID:Cholestasis induced by total parenteral nutrition. 1824 99